In ovarian cancer, overproduction of both inteleukin-6 (IL-6) and thrombopoetin by the tumors are causative of thrombocytosis, which results in maintenance of tumor microvessel integrity and pericyte support in an autocrine feedback loop [11,28]. The gene discussed is IL6; the disease is thrombocytosis disease.